U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753265) titled 'A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine' on Aug. 04.
Brief Summary: Evaluate the immunogenicity after boost vaccination with the live attenuated herpes zoster vaccine.
Study Start Date: Aug. 13
Study Type: INTERVENTIONAL
Condition:
Herpse Zoster
Intervention:
BIOLOGICAL: live-attenuated zoster vaccine
one dose of live-attenuated zoster vaccine to the particpent only administered one dose of recombinant zoster vaccine
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Changchun BCHT Biotechnology Co.
Published by HT Digital Content Serv...